Jelena Belic

1.5k total citations
17 papers, 870 citations indexed

About

Jelena Belic is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Jelena Belic has authored 17 papers receiving a total of 870 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cancer Research, 10 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in Jelena Belic's work include Cancer Genomics and Diagnostics (15 papers), Lung Cancer Treatments and Mutations (6 papers) and Prostate Cancer Treatment and Research (4 papers). Jelena Belic is often cited by papers focused on Cancer Genomics and Diagnostics (15 papers), Lung Cancer Treatments and Mutations (6 papers) and Prostate Cancer Treatment and Research (4 papers). Jelena Belic collaborates with scholars based in Austria, United Kingdom and United States. Jelena Belic's co-authors include Ellen Heitzer, Michael R. Speicher, Martina Auer, Jochen B. Geigl, Peter Ulz, Katja Fischereder, Gerald Höefler, Thomas Bauernhofer, Martin Pichler and Herbert Augustin and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Jelena Belic

16 papers receiving 862 citations

Peers

Countries citing papers authored by Jelena Belic

Since Specialization

Citations

This map shows the geographic impact of Jelena Belic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jelena Belic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jelena Belic more than expected).

Fields of papers citing papers by Jelena Belic

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jelena Belic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jelena Belic. The network helps show where Jelena Belic may publish in the future.

Co-authorship network of co-authors of Jelena Belic

This figure shows the co-authorship network connecting the top 25 collaborators of Jelena Belic. A scholar is included among the top collaborators of Jelena Belic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jelena Belic. Jelena Belic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Longitudinal monitoring of disease burden and response using ctDNA from dried blood spots in xenograft models 2022 ·EMBO Molecular Medicine ·Carolin M. Sauer, Katrin Heider, Jelena Belic, (unknown), James Hall, Dominique‐Laurent Couturier, (unknown), (unknown), Marika Reinius, Karen Hosking, Maria Vias, Nitzan Rosenfeld, James D. Brenton	11
2	Detection of ctDNA from Dried Blood Spots after DNA Size Selection 2020 ·Clinical Chemistry ·Katrin Heider, Jonathan C. M. Wan, James Hall, Jelena Belic, (unknown), Irena Hudecova, Davina Gale, Wendy N. Cooper, Pippa Corrie, James D. Brenton, Christopher G. Smith, Nitzan Rosenfeld	36
3	On-treatment measurements of circulating tumor DNA during FOLFOX therapy in patients with colorectal cancer 2020 ·npj Precision Oncology ·Tina Moser, Julie Waldispuehl‐Geigl, Jelena Belic, Sabrina Weber, Qing Zhou, (unknown), Ricarda Graf, (unknown), Florian Posch, Heinz Sill, Sigurd Lax, Karl Kashofer, Gerald Höefler, Helmut Schoellnast, Ellen Heitzer, Jochen B. Geigl, Thomas Bauernhofer, Michael R. Speicher	23
4	A higher ctDNA fraction decreases survival in regorafenib‐treated metastatic colorectal cancer patients. Results from the regorafenib's liquid biopsy translational biomarker phase II pilot study 2020 ·International Journal of Cancer ·Matthias Unseld, Jelena Belic, (unknown), Qing Zhou, Tina Moser, (unknown), (unknown), Armin Gerger, Alexander Siebenhüner, Michael R. Speicher, Ellen Heitzer, Gerald W. Prager	12
5	Shallow Whole-Genome Sequencing from Plasma Identifies FGFR1 Amplified Breast Cancers and Predicts Overall Survival 2020 ·Cancers ·(unknown), Jean‐Yves Pierga, (unknown), (unknown), Charlotte Proudhon, Michael R. Speicher, Jelena Belic, Ellen Heitzer, Brian Lockhart, Nolwen Guigal-Stéphan	13
6	Abstract 735: Sensitive detection of ctDNA in early stage non-small cell lung cancer patients with a personalized sequencing assay 2020 ·Cancer Research ·Katrin Heider, Davina Gale, Andrea Ruiz-Valdepeñas, Giovanni Marsico, Garima Sharma, (unknown), Robert J. Osborne, Karen Howarth, (unknown), (unknown), Jelena Belic, Jerome Wulff, Susan Harden, Doris M. Rassl, Robert C. Rintoul, Nitzan Rosenfeld	4
7	Detection of residual disease and recurrence in early-stage non-small cell lung cancer (NSCLC) patients using sensitive personalized ctDNA sequencing assays. 2020 ·Journal of Clinical Oncology ·Katrin Heider, Davina Gale, Giovanni Marsico, Andrea Ruiz-Valdepeñas, Garima Sharma, (unknown), Robert J. Osborne, Karen Howarth, (unknown), Jelena Belic, Jerome Wulff, Susan Harden, Doris M. Rassl, Robert C. Rintoul, Nitzan Rosenfeld	5
8	Genomic alterations in plasma DNA from patients with metastasized prostate cancer receiving abiraterone or enzalutamide 2018 ·International Journal of Cancer ·Jelena Belic, Ricarda Graf, Thomas Bauernhofer, (unknown), Peter Ulz, Julie Waldispuehl‐Geigl, Samantha Perakis, Michael Gormley, Jaymala Patel, Weimin Li, Jochen B. Geigl, Denis A. Smirnov, Ellen Heitzer, Mitchell E. Gross, Michael R. Speicher	40
9	Advances in Circulating Tumor DNA Analysis 2017 ·Advances in clinical chemistry ·Samantha Perakis, Martina Auer, Jelena Belic, Ellen Heitzer	22
10	Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer 2016 ·Nature Communications ·Peter Ulz, Jelena Belic, Ricarda Graf, Martina Auer, Ingrid Lafer, Katja Fischereder, Gerald Webersinke, Karl Pummer, Herbert Augustin, Martin Pichler, Gerald Höefler, Thomas Bauernhofer, Jochen B. Geigl, Ellen Heitzer, Michael R. Speicher	110
11	mFast-SeqS as a Monitoring and Pre-screening Tool for Tumor-Specific Aneuploidy in Plasma DNA 2016 ·Advances in experimental medicine and biology ·Jelena Belic, (unknown), Peter Ulz, Martina Auer, Teresa Gerhalter, Sumitra Mohan, Katja Fischereder, Edgar Petru, Thomas Bauernhofer, Jochen B. Geigl, Michael R. Speicher, Ellen Heitzer	23
12	Potentials, challenges and limitations of a molecular characterization of circulating tumor DNA for the management of cancer patients 2016 ·LaboratoriumsMedizin ·Peter Ulz, Armin Gerger, Jelena Belic, Ellen Heitzer	0
13	Whole-genome sequencing of circulating tumor DNA reveals relevance of focal amplifications for the management of metastatic prostate cancer 2016 ·European Journal of Cancer ·Jelena Belic, Peter Ulz, Ryon P. Graf, Martina Auer, Katja Fischereder, Gerald Höefler, Thomas Bauernhofer, (unknown), Ellen Heitzer, Michael R. Speicher	8
14	Somatic CRISPR/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modelling 2015 ·Nature Communications ·Marc Zuckermann, Volker Hovestadt, Christiane B. Knobbe‐Thomsen, Marc Zapatka, Paul A. Northcott, Kathrin Schramm, Jelena Belic, David Jones, Barbara R. Tschida, Branden S. Moriarity, David A. Largaespada, Martine F. Roussel, Andrey Korshunov, Guido Reifenberger, Stefan M. Pfister, Peter Lichter, Daisuke Kawauchi, Jan Gronych	220
15	Rapid Identification of Plasma DNA Samples with Increased ctDNA Levels by a Modified FAST-SeqS Approach 2015 ·Clinical Chemistry ·Jelena Belic, (unknown), Peter Ulz, Martina Auer, Teresa Gerhalter, Sumitra Mohan, Katja Fischereder, Edgar Petru, Thomas Bauernhofer, Jochen B. Geigl, Michael R. Speicher, Ellen Heitzer	79
16	Abstract PR02: Somatic CRISPR/Cas9-mediated tumor suppressor disruption enables versatile brain tumor modeling 2015 ·Cancer Research ·Marc Zuckermann, Volker Hovestadt, Christiane B. Knobbe‐Thomsen, Marc Zapatka, Paul A. Northcott, Kathrin Schramm, Jelena Belic, David Jones, Barbara R. Tschida, Branden S. Moriarity, David A. Largaespada, Martine F. Roussel, Andrey Korshunov, Guido Reifenberger, Stefan M. Pfister, Peter Lichter, Daisuke Kawauchi, Jan Gronych	1
17	Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing 2013 ·Genome Medicine ·Ellen Heitzer, Peter Ulz, Jelena Belic, (unknown), Franz Quehenberger, Katja Fischereder, Theresa Benezeder, Martina Auer, (unknown), Sebastian Mannweiler, Martin Pichler, Florian Eisner, Martin Haeusler, Sabine Riethdorf, Klaus Pantel, Hellmut Samonigg, Gerald Höefler, Herbert Augustin, Jochen B. Geigl, Michael R. Speicher	263

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact